Clozapine is associated with secondary antibody deficiency

BACKGROUND: Schizophrenia affects 1% of the population. Clozapine is the only medication licensed for treatment-resistant schizophrenia and is intensively monitored to prevent harm from neutropenia. Clozapine is also associated with increased risk of pneumonia although the mechanism is poorly unders...

Descripción completa

Detalles Bibliográficos
Autores principales: Ponsford, Mark, Castle, Daniel, Tahir, Tayyeb, Robinson, Rebecca, Wade, Wendy, Steven, Rachael, Bramhall, Kathryn, Moody, Mo, Carne, Emily, Ford, Catherine, Farewell, Daniel, Williams, Paul, El-Shanawany, Tariq, Jolles, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2019
Materias:
Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429246/
https://www.ncbi.nlm.nih.gov/pubmed/30259827
http://dx.doi.org/10.1192/bjp.2018.152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429246/
https://www.ncbi.nlm.nih.gov/pubmed/30259827
http://dx.doi.org/10.1192/bjp.2018.152

Ejemplares similares